Cardiocentro Ticino
Clinical trials sponsored by Cardiocentro Ticino, explained in plain language.
-
Heart bypass gets safer? new drug trial aims to prevent clots during surgery
Disease control Recruiting nowThis study tests whether giving the blood thinner cangrelor during a minimally invasive heart bypass (MIDCAB) is safe and helps prevent dangerous blood clots. About 30 adults with coronary artery disease will receive cangrelor through an IV during surgery, and their outcomes will…
Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Heart stent patients get personalized blood thinner dosing in new study
Disease control Recruiting nowThis study looks for the best type and dose of a single blood thinner (P2Y12 inhibitor) for people who have had a heart stent placed. About 355 participants will try different doses to find the sweet spot that prevents blood clots without causing dangerous bleeding. The goal is t…
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
AI could catch heart attacks standard tests miss
Diagnosis Recruiting nowThis study tests whether an artificial intelligence (AI) tool can help doctors diagnose a certain type of heart attack (occlusion myocardial infarction) earlier in people with symptoms but unclear standard ECG results. About 500 adults will be randomly assigned to have their ECG …
Phase: NA • Sponsor: Cardiocentro Ticino • Aim: Diagnosis
Last updated May 26, 2026 03:36 UTC
-
New heart ablation tool could cut radiation for AFib patients
Symptom relief Recruiting nowThis study compares two catheters used to treat atrial fibrillation (AFib) by isolating the pulmonary veins. The newer catheter has built-in navigation that may eliminate the need for a pre-procedure CT scan, reducing radiation exposure and costs. About 58 adults with AFib who ar…
Phase: NA • Sponsor: Cardiocentro Ticino • Aim: Symptom relief
Last updated May 26, 2026 03:36 UTC